Retrovirology highlights a quarter century of HTLV-I research.
In 1977, Takatsuki and co-workers described in Japan a human malignant disease termed adult T-cell leukemia (ATL). Three years later, in 1980, Gallo and colleagues reported the identification of the first human retrovirus, human T-cell leukemia virus type I (HTLV-I), in a patient with cutaneous T-cell lymphoma. This month, Retrovirology commemorates these two land mark findings by publishing separate personal recollections by Takatsuki and Gallo respectively on the discovery of ATL and HTLV.
Jeang
Kuan-Teh
KT
Laboratory of Molecular Microbiology, NIAID, NIH Bethesda, Maryland 20892, USA. kj7e@nih.gov
D000818:Animals; D002472:Cell Transformation, Viral; D016356:Gene Products, tax / Q000378:metabolism; D049673:History, 20th Century; D015368:Human T-lymphotropic virus 1 / Q000472:pathogenicity* / Q000502:physiology; D006801:Humans; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000266:history*; D012106:Research / Q000266:history*; D012190:Retroviridae / Q000472:pathogenicity* / Q000502:physiology
D016356:Gene Products, tax
Retrovirology. 2005;2:17
15743526
Annu Rev Immunol. 2001;19:475-96
11244044
J Exp Med. 1910 Sep 1;12(5):696-705
19867354
J Biol Chem. 2004 Jul 30;279(31):31991-4
15090550
Nature. 1976 Mar 11;260(5547):170-3
176594
Retrovirology. 2005;2:16
15743528